News

None have been approved by the Food and Drug Administration so far, though in 2019, Johnson & Johnson received FDA permission ...
(WYTV) – More than seven million people have Alzheimer’s disease in the United States. Now a new blood test may be able to ...
Gammagard Liquid ERC is a ready-to-use formulation with low IgA content designed to ease administration burden by removing the need to reconstitute.
The Food and Drug Administration has approved a new drug that could prevent HIV infections with just two shots every year and ...
Clinical trials showed 99.9% of participants who received the drug, called Yeztugo​ from company Gilead Sciences, remained ...
Clinical trials have shown that six-monthly injections of lenacapavir are almost 100 percent protective against becoming ...
Synthetic products posing as kratom mislead and endanger consumers; AKA urges FDA to take decisive action against violative ...
For the 2025-2026 respiratory viral season, Moderna intends to have mResvia available for both FDA-approved patient populations.
The approval was supported by pooled data from 2 open-label, single arm trials: the phase 2 NI-0501-06 study and the phase 3 EMERALD trial.
The Food and Drug Administration has approved a highly effective new HIV-prevention medication, Gilead Sciences reported ...
Despite a growing number of state bans, advocates of cultivated seafood say it can protect waterways from overfishing.
News about Food and Drug Administration, including commentary and archival articles published in The New York Times.